Abstract |
Increasing resistance to currently available influenza antivirals highlights the need to develop alternate approaches for the prevention and/or treatment of influenza. DAS181 (Fludase), a novel sialidase fusion protein that enzymatically removes sialic acids on respiratory epithelium, exhibits potent antiviral activity against influenza A and B viruses. Here, we use a mouse model to evaluate the efficacy of DAS181 treatment against a highly pathogenic avian influenza H5N1 virus. When used to treat mice daily beginning 1 day before infection with A/Vietnam/1203/2004(H5N1) virus, DAS181 treatment at 1 mg/kg/day protected 100% of mice from fatal disease, prevented viral dissemination to the brain, and effectively blocked infection in 70% of mice. DAS181 at 1 mg/kg/day was also effective therapeutically, conferring enhanced survival of H5N1 virus-challenged mice when treatment was begun 72 h after infection. This notable antiviral activity underscores the potential utility of DAS181 as a new class of drug that is effective against influenza viruses with pandemic potential.
|
Authors | Jessica A Belser, Xiuhua Lu, Kristy J Szretter, Xiaoping Jin, Laura M Aschenbrenner, Alice Lee, Stephen Hawley, Do Hyong Kim, Michael P Malakhov, Mang Yu, Fang Fang, Jacqueline M Katz |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 196
Issue 10
Pg. 1493-9
(Nov 15 2007)
ISSN: 0022-1899 [Print] United States |
PMID | 18008229
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antiviral Agents
- Recombinant Fusion Proteins
- Sialic Acids
- Viral Fusion Proteins
- oplunofusp
|
Topics |
- Animals
- Antiviral Agents
(administration & dosage, pharmacology)
- Brain
(virology)
- Disease Models, Animal
- Female
- Humans
- Influenza A Virus, H5N1 Subtype
(drug effects, pathogenicity)
- Influenza, Human
(prevention & control, virology)
- Lung
(virology)
- Mice
- Mice, Inbred BALB C
- Recombinant Fusion Proteins
(pharmacology)
- Sialic Acids
(administration & dosage, pharmacology)
- Viral Fusion Proteins
(administration & dosage, pharmacology)
|